Ligand Pharmaceuticals Incorporated
USD303.39
+6.94 (+2.34%)
CEO
Todd C. Davis
IPO Date
1992-11-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$294.72
Prev. Close
$296.45
Day Low
$290.20
Day High
$305.60
52W Low
$129.55
52W High
$326.63
Market Cap
$6.08B
Volume
0.28M
| 5,000 |
| $52.27 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 396 | $308.99 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 104 | $310.20 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 1,119 | $311.72 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 1,081 | $312.28 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 700 | $313.46 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 100 | $314.58 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 900 | $315.78 |
| 6 Jul 2026 | Reardon Andrew | CLO & Secretary | S-Sale | Disposed | 600 | $317.15 |
| $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 3 Dec 2020 | Katherine M. Clark | Katherine M. Clark | Sale (Full) | $1,001 - $15,000 |